Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.


Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
06 2020
Historique:
received: 15 02 2020
accepted: 24 02 2020
pubmed: 28 2 2020
medline: 1 7 2020
entrez: 28 2 2020
Statut: ppublish

Résumé

To investigate the evolutionary history of the recent outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China, a total of 70 genomes of virus strains from China and elsewhere with sampling dates between 24 December 2019 and 3 February 2020 were analyzed. To explore the potential intermediate animal host of the SARS-CoV-2 virus, we reanalyzed virome data sets from pangolins and representative SARS-related coronaviruses isolates from bats, with particular attention paid to the spike glycoprotein gene. We performed phylogenetic, split network, transmission network, likelihood-mapping, and comparative analyses of the genomes. Based on Bayesian time-scaled phylogenetic analysis using the tip-dating method, we estimated the time to the most recent common ancestor and evolutionary rate of SARS-CoV-2, which ranged from 22 to 24 November 2019 and 1.19 to 1.31 × 10

Identifiants

pubmed: 32104911
doi: 10.1002/jmv.25731
pmc: PMC7228310
doi:

Substances chimiques

Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

602-611

Subventions

Organisme : K.C. Wong Magna Fund in Ningbo University
Pays : International
Organisme : National Natural Science Foundation of China
ID : 31470268
Pays : International

Informations de copyright

© 2020 Wiley Periodicals, Inc.

Références

Emerg Infect Dis. 2014 Jun;20(6):1049-53
pubmed: 24856660
N Engl J Med. 2012 Nov 8;367(19):1814-20
pubmed: 23075143
J Virol. 1999 Jan;73(1):152-60
pubmed: 9847317
Chembiochem. 2004 Dec 3;5(12):1653-61
pubmed: 15526330
Curr Protoc Bioinformatics. 2007 Mar;Chapter 6:Unit 6.6
pubmed: 18428792
Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):11030-5
pubmed: 15258291
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
J Mol Evol. 1980 Dec;16(2):111-20
pubmed: 7463489
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
N Engl J Med. 2003 May 15;348(20):1953-66
pubmed: 12690092
Lancet. 2013 Dec 14;382(9909):1993-2002
pubmed: 24055451
J Virol. 2013 Jul;87(14):7790-2
pubmed: 23678167
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
mBio. 2014 Feb 18;5(1):
pubmed: 24549846
J Med Virol. 2020 Jun;92(6):602-611
pubmed: 32104911
Nat Methods. 2012 Jul 30;9(8):772
pubmed: 22847109
Syst Biol. 2018 Sep 1;67(5):901-904
pubmed: 29718447
Science. 2003 Oct 10;302(5643):276-8
pubmed: 12958366
Science. 2004 Mar 12;303(5664):1666-9
pubmed: 14752165
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
BMC Evol Biol. 2004 Jun 28;4:21
pubmed: 15222897
Virus Evol. 2018 Jan 08;4(1):vex042
pubmed: 29340210
J Biol Chem. 1994 Apr 22;269(16):12240-7
pubmed: 8163529
J Vis Exp. 2019 Jan 9;(143):
pubmed: 30688313
PLoS Biol. 2006 May;4(5):e88
pubmed: 16683862
J Virol. 2010 Mar;84(6):2808-19
pubmed: 20071579
Mol Biol Evol. 2006 Feb;23(2):254-67
pubmed: 16221896
N Engl J Med. 2003 May 15;348(20):1967-76
pubmed: 12690091
Mol Biol Evol. 1987 Jul;4(4):406-25
pubmed: 3447015
Bioinformatics. 2002 Mar;18(3):502-4
pubmed: 11934758
J Med Virol. 2020 May;92(5):501-511
pubmed: 32027035
Viruses. 2019 Oct 24;11(11):
pubmed: 31652964
Mol Biol Evol. 2012 Aug;29(8):1969-73
pubmed: 22367748
Virus Res. 1999 Mar;60(1):55-65
pubmed: 10225274
Bioinformatics. 2009 Jun 1;25(11):1370-6
pubmed: 19369496
Trends Microbiol. 2016 Jun;24(6):490-502
pubmed: 27012512
Lancet. 2003 Oct 25;362(9393):1353-8
pubmed: 14585636
J Mol Evol. 1984;20(1):86-93
pubmed: 6429346
Biochim Biophys Acta. 2000 Nov 10;1469(3):121-32
pubmed: 11063880
Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14040-5
pubmed: 16169905
Sci Rep. 2018 Nov 9;8(1):16597
pubmed: 30413791
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300
Evolution. 1985 Jul;39(4):783-791
pubmed: 28561359
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
Mol Biol Evol. 2018 Jul 1;35(7):1812-1819
pubmed: 29401317
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
J Med Virol. 2020 Apr;92(4):448-454
pubmed: 31997390
Emerg Infect Dis. 2005 Dec;11(12):1860-5
pubmed: 16485471
Emerg Infect Dis. 2014 Dec;20(12):2093-5
pubmed: 25425139
Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2430-5
pubmed: 15695582
J Virol. 2015 Aug;89(15):8077-81
pubmed: 25972540
Science. 2005 Oct 28;310(5748):676-9
pubmed: 16195424
Syst Biol. 2010 May;59(3):307-21
pubmed: 20525638

Auteurs

Xingguang Li (X)

Hubei Engineering Research Center of Viral Vector, Wuhan University of Bioengineering, Wuhan, China.

Junjie Zai (J)

Immunology Innovation Team, School of Medicine, Ningbo University, Ningbo, China.

Qiang Zhao (Q)

Precision Cancer Center Airport Center, Tianjin Cancer Hospital Airport Hospital, Tianjin, China.

Qing Nie (Q)

Department of Microbiology, Weifang Center for Disease Control and Prevention, Weifang, China.

Yi Li (Y)

Hubei Engineering Research Center of Viral Vector, Wuhan University of Bioengineering, Wuhan, China.

Brian T Foley (BT)

HIV Databases, Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, New Mexico.

Antoine Chaillon (A)

Department of Medicine, University of California San Diego, La Jolla, California.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH